🇺🇸 FDA
Pipeline program

Combination of chemotherapy and immunotherapy

BF2025-340

Unknown small_molecule active

Quick answer

Combination of chemotherapy and immunotherapy for Non Small Cell Lung Cancer is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Non Small Cell Lung Cancer
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials